To be exact about it, anti-emetics are a clinical decision and not a self-management step.
Trial incidence for vomiting runs at roughly a third to a half of the nausea rate depending on agent and dose, and it is more concentrated in the escalation phase than nausea is.
Warning signs that convert this from a nuisance to a clinical problem: inability to keep fluids down for more than a few hours, reduced urine output, dizziness on standing, confusion, or severe abdominal pain.
Oral rehydration solution composition is standardised by the World Health Organization and rests on glucose-coupled sodium transport.
Anti-emetics interact with other medication and are a prescriber decision.
The renal risk here is volume, not toxicity. That is the mechanism to watch.